Recursion Pharmaceuticals (RXRX) EBIT Margin (2020 - 2026)
Recursion Pharmaceuticals (RXRX) posted EBIT Margin of -1759.69% for Q2 2026, down 842.94 percentage points from -916.75% a year earlier but up 225.87 percentage points from the prior quarter.
Recursion Pharmaceuticals (RXRX) EBIT Margin (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at Recursion Pharmaceuticals was -991.72%, up 14.09 percentage points year-over-year; for FY2025, it came in at -867.87%, down 53.77 percentage points from FY2024.
- Annual EBIT Margin has declined for three consecutive years, though with a five-year change of +1267.80 percentage points (FY2020 to FY2025).
- In prior years, Recursion Pharmaceuticals' EBIT Margin was -814.09% in FY2024 (-28.76 pp), -785.33% in FY2023 (-168.59 pp), -616.74% in FY2022 (+1179.05 pp) and -1795.79% in FY2021 (+339.88 pp).
- Quarterly EBIT Margin has run from a low of -4042.41% in Q4 2024 to a high of -304.84% in Q4 2025 over five years.
- On a year-over-year basis, EBIT Margin increased in two of the last eight quarters, with an average year-over-year change of -516.04 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2025, with a gain of 3737.57 percentage points; the weakest was Q4 2024, with a drop of 3134.05 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -1985.55% (Q1 2026), -304.84% (Q4 2025) and -3327.57% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Recursion Pharmaceuticals | 1.98 Bn | -627.04 Mn | -3.82 Mn | -1,759.69% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,759.69% |
| Mar 31, 2026 | -1,985.55% |
| Dec 31, 2025 | -304.84% |
| Sep 30, 2025 | -3,327.57% |
| Jun 30, 2025 | -916.75% |
| Mar 31, 2025 | -1,297.85% |
| Dec 31, 2024 | -4,042.41% |
| Sep 30, 2024 | -377.10% |
| Jun 30, 2024 | -697.39% |
| Mar 31, 2024 | -698.42% |
| Dec 31, 2023 | -908.36% |
| Sep 30, 2023 | -945.12% |
| Jun 30, 2023 | -741.72% |
| Mar 31, 2023 | -575.78% |
| Dec 31, 2022 | -445.91% |
| Sep 30, 2022 | -475.48% |
| Jun 30, 2022 | -862.54% |
| Mar 31, 2022 | -1,049.71% |
| Dec 31, 2021 | -2,564.55% |
| Sep 30, 2021 | -1,831.18% |
Recursion Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();